GHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 was the first synthetic GHRP to be widely studied and remains one of the most characterised. As a hexapeptide ghrelin receptor agonist, it produces robust GH pulses but is distinguished by its strong appetite stimulation — a consequence of its high ghrelin receptor potency. This property makes it relevant not only for GH optimisation but as a model compound for ghrelin biology research.
Mechanism of Action
GHRP-6 activates ghrelin receptors (GHSR-1a) in both the hypothalamus and pituitary. Hypothalamic activation reduces somatostatin release (enabling larger GH pulses) and strongly activates appetite pathways — explaining the pronounced hunger effect compared to the more selective Ipamorelin.
GHRP-6 also stimulates ACTH and cortisol release at supra-threshold doses, similarly to GHRP-2. This adrenal axis co-stimulation is dose-dependent and is the main clinical limitation for long-term use compared to newer selective GHRPs.
Because GHRP-6 so closely mimics endogenous ghrelin at its target receptor, it has been extensively used in basic research to characterise ghrelin receptor biology, making it one of the most studied GHRPs despite being superseded in clinical practice by more selective compounds.
Research Evidence
GHRP-6 was one of the earliest compounds to enter GHRP clinical research, with human trials dating to the early 1990s. It has been used as a reference compound for characterising GHRP biology and ghrelin receptor pharmacology.
GHRP-6 Stimulates GH Release: Dose-Response in Healthy Adults
GHRP-6 produced robust, dose-dependent GH pulses in healthy adults with a peak at 1–3 mcg/kg IV, establishing its clinical pharmacological profile as a pituitary secretagogue.
Typical Research Protocol
Often combined with a GHRH analogue (CJC-1295 or Sermorelin). Appetite stimulation is pronounced — meal planning around dosing is important for body composition protocols where caloric control is needed. Capping at 200 mcg/injection reduces cortisol co-stimulation.
Safety Profile
Reported Side Effects
- Significant appetite increase (most common)
- Cortisol elevation (dose-dependent)
- Prolactin increase (transient)
- Water retention
- Tingling
- Headache
Contraindications
- Active malignancy
- Eating disorders (appetite amplification concern)
- Hypothyroidism
- Pregnancy
- Insulin resistance / uncontrolled diabetes
Published Research
638 indexed PubMed papers reference GHRP-6. The 20 most recent are listed below.
- Ghrelin Receptor Blockade Restricts Hepatic Echinococcus granulosus Infection by Suppressing Host Cell Proliferation and Enhancing Fibrotic Encapsulation.
- Ghrelin attenuates hypoxia-induced mitochondrial oxidative stress damage in HTR-8/SVneo trophoblasts.
- Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.
- Ghrelin impairs embryo development after ovarian hyperstimulation.
- The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.
- The Ghrelin/GHSR-1a Axis Attenuates Preeclampsia-like Features with Decidual Macrophage Reprogramming and Improved Placental Remodeling.
- Growth Hormone-Releasing Peptide-6 (GHRP-6) Ameliorates Post-Infarct Ventricular Remodeling and Systolic Dysfunction in a Model of Permanent Coronary Ligation.
- Growth hormone releasing peptide-6 (GHRP-6) ameliorates acute lung injury and its subsequent evolvement to interstitial fibrosis.
- Oral salmon acylated ghrelin increases food intake in common carp (Cyprinus carpio) via ghrelin receptors, likely through sensory nerves rather than systemic absorption.
- Effect of intracerebroventricular (ICV) injection of antimicrobial peptide expressed in the body-2 (LEAP-2) and its interaction with cannabinoid and ghrelin systems on food intake in broiler chickens.
- Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulation.
- Aza-Isotryptophan: Synthesis, Pictet-Spengler Chemistry, Incorporation and Conformational Analysis in Peptides, and Activity in Modulators of the Cluster of Differentiation-36 Receptor.
- Assessing The Effectiveness of Growth Hormone Releasing Protein-6 in Improving Human Oocyte Maturation and Meiotic Progression in In Vitro Maturation Culture Media.
- The Ghrelin Analog GHRP-6, Delivered Through Aquafeeds, Modulates the Endocrine and Immune Responses of Sparus aurata Following IFA Treatment.
- A novel butyrylcholinesterase inhibitor induces antidepressant, pro-cognitive, and anti-anhedonic effects in Flinders Sensitive Line rats: The role of the ghrelin-dopamine cascade.
- Danshen-Chuanxiong-Honghua ameliorates neurological function and inflammation in traumatic brain injury in rats via modulating Ghrelin/GHSR.
- GHSR gene knockout alleviates the liver pathological response in Echinococcus granulosus infection by reducing parasite survival.
- Ghrelin promotes neurologic recovery and neurogenesis in the chronic phase after experimental stroke.
- Subchronic safety assessment of CIGB-500 in beagle dog after repeated daily dose administration over 28 days.
- Ghrelin suppresses water intake with a different physiological significance from atrial natriuretic peptide in conscious seawater-acclimated eels.
Common Research Stacks
Frequently Asked Questions
Why does GHRP-6 cause such strong hunger?
GHRP-6 potently activates ghrelin receptors (GHSR-1a), and ghrelin is the primary hunger hormone. Unlike Ipamorelin which has high GHSR selectivity for the pituitary GH-releasing pathway, GHRP-6 activates all aspects of the ghrelin receptor system — including the hypothalamic orexigenic (appetite-driving) pathways. This is intrinsic to its pharmacology and occurs even at doses that produce modest GH responses.
Is GHRP-6 more powerful than Ipamorelin?
At equivalent doses, GHRP-6 typically produces larger GH pulses than Ipamorelin, partly due to its hypothalamic somatostatin suppression effect. However, the cortisol and prolactin co-stimulation at higher GHRP-6 doses, combined with pronounced appetite stimulation, means Ipamorelin is generally preferred for sustained clean GH optimisation protocols.
Can GHRP-6 be used for muscle building?
Yes — GHRP-6 is used in body composition research. The combination of strong GH pulses (via GHSR-1a activation) with appetite stimulation (via ghrelin pathways) creates an environment favourable for muscle mass gain when combined with high protein intake and resistance training. The appetite increase, while a side effect in fat loss protocols, becomes an asset for bulk-focused research.
What is the difference between GHRP-6 and GHRP-2?
Both are hexapeptide GHRPs producing GH pulses with cortisol and prolactin co-stimulation. GHRP-6 produces stronger appetite stimulation and somewhat more pronounced cortisol elevation at equivalent doses. GHRP-2 (Pralmorelin) has more clinical data and pharmaceutical-grade manufacturing history (approved in Japan). For protocols where appetite stimulation is undesirable, GHRP-2 is slightly preferred over GHRP-6.
How should GHRP-6 be stored and reconstituted?
Lyophilised GHRP-6 should be stored at -20°C for long-term storage (up to 2 years) or 4°C for up to 6 months. Reconstitute with bacteriostatic water (BAC water) at your desired concentration. Reconstituted solution should be stored at 4°C and used within 4 weeks. Do not freeze reconstituted peptide.
Key Research References
- Bowers CY et al. (1991). On the in vitro and in vivo activity of a new synthetic hexapeptide. Endocrinology.
- Laferrère B et al. (1995). GHRP-6 stimulates GH secretion in humans. J Clin Endocrinol Metab.
Explore more Growth Hormone research compounds
Browse Growth Hormone →